Upon entry, glutamine is converted to glutamate by glutaminase (GLS), an enzyme directly targeted by miR-153, and miR-203, frequently downregulated in glioblastoma and melanoma, respectively [60, 61]. The gene discussed is GLS; the disease is melanoma.